{{Rsnum
|rsid=1930293
|Chromosome=1
|position=184325033
|Orientation=minus
|GMAF=0.1708
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 64.6 | 31.9 | 3.5
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 36.7 | 44.2 | 19.0
| ASW | 50.9 | 29.8 | 19.3
| CHB | 100.0 | 0.0 | 0.0
| CHD | 99.1 | 0.9 | 0.0
| GIH | 68.3 | 29.7 | 2.0
| LWK | 42.7 | 44.5 | 12.7
| MEX | 69.0 | 27.6 | 3.4
| MKK | 51.3 | 37.2 | 11.5
| TSI | 69.6 | 27.5 | 2.9
| HapMapRevision=28
}}rs1930293 increases susceptibility to [[prostate cancer]] 1.20 times for heterozygotes (AG) and 1.70 times for homozygotes (GG) {{PMID|17876339}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}